Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  DAIICHI SANKYO COMPANY, LIMITED    4568   JP3475350009

SummaryChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

DAIICHI S : Notice on Details of the Share Options

07/12/2011 | 04:20am US/Eastern
For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, President and CEO

(Code no.: 4568, First Section of Tokyo, Osaka and Nagoya Stock Exchanges) Please address inquiries to Toshiaki Sai, Corporate Officer, Vice President, Corporate Communications Department

Telephone: +81-3-6225-1126 on Details of the Share OptionsTOKYO, Japan (July 12, 2011) Daiichi Sankyo Company, Limited has announced that the subscription amount and other details of its No.5 share options were decided today. As previously announced, the Board of Directors had reached a decision on June 27, 2011 to issue the said share remuneration-type stock options (share options) to remunerate Directors (excluding Outside Directors) and Corporate Officers

1. Name of share options

Daiichi Sankyo Company, Limited No. 5 share options

2. Total number of share options

2,328 share options (100 shares per one share option) Breakdown

Six (6) Directors: 1,102 share options

Eighteen (18) Corporate Officers: 1,226 share options

3. Subscription amount for share options

111,200 yen per share option

(1,112 yen per share)


Date of Board of Directors resolution: June 27, 2011

React to this article
13h ago DAIICHI SANKYO : Plexxikon Assigned Patent
1d ago DAIICHI SANKYO : launches new formulation of LIXIANA 60 mg tablets in Japan
1d ago RANBAXY LABORATORIES : CCI Approves Sun-Ranbaxy Deal But With Riders
4d ago DAIICHI SANKYO : Launches New Formulation of LIXIANA® 60 mg Tablets edoxaban in ..
5d ago DAIICHI SANKYO : American Regent Announces Clinical Data Presentations at ASH 20..
5d ago RANBAXY LABORATORIES : "Process for the Preparation of Dexlansoprazole" in Paten..
5d ago RANBAXY LABORATORIES : Labs to take its novel drug Synriam to Africa
6d ago Asian business sentiment rebounds in fourth-quarter with India most optimisti..
6d ago Thomson Reuters/INSEAD Asia Business Sentiment Survey fourth quarter 2014 - P..
6d ago Sun hoists its flag on domestic pharma landscape
Duration : Period :
DAIICHI SANKYO COMPANY, LI Technical Analysis Chart | 4568 | JP3475350009 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes